It was found that AIM2 overexpression inhibited the mammalian target of the rapamycin (mTOR)-ribosomal S6 kinase 1 (S6K1) pathway and further blocked proliferation, colony formation, and the invasion of HCC cells [49]. This evidence concerns the gene AIM2 and hepatocellular carcinoma.